中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:( Dexin KONG)

1.Research progress in erythropoietin mimetic peptides

Yan DONG ; Weiren XU ; Dexin KONG

Tianjin Medical Journal 2015;(1):102-105

2.Fifteen Years' Blood Pressure Change in 1079 Workers

Zunzhong ZHAO ; Wanlun GUO ; Shanxiang LIU ; Dexin SHANG ; Qingyin KONG ; Honglian WEI ; Shiyun HUANG ; Mingshan WANG

Chinese Journal of Hypertension 2001;9(1):68-71

3.The practice of multidisciplinary team model in cancer diagnosis and treatment in the primary hospitals

Guofeng ZHANG ; Dexin KONG ; Yingjie YIN ; Xiaocheng LIU ; Rui KANG ; Zhanlong SHEN

Chinese Journal of General Surgery 2017;32(7):616-618

4.An exploratory study on occupational stress and work-related unintentional injury in off-shore oil production.

Weiqing CHEN ; Zihui HUANG ; Dexin YU ; Yanzu LIN ; Zhiming LING ; Jinsong TANG

Chinese Journal of Epidemiology 2002;23(6):441-444

5.Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1

Shan GAO ; Tingting GUO ; Shuyu LUO ; Yan ZHANG ; Zehao REN ; Xiaona LANG ; Gaoyong HU ; Duo ZUO ; Wenqing JIA ; Dexin KONG ; Haiyang YU ; Yuling QIU

Biomolecules & Therapeutics 2022;30(6):553-561

6.Effect and mechanism of Stellettin B induced human glioblastoma SF295 cells autophagy

Chang ZHOU ; Qian ZHANG ; Xin PENG ; Zhengming WANG ; Yao LIU ; Zhe ZHANG ; Ran WANG ; Dexin KONG

International Journal of Biomedical Engineering 2018;41(2):125-130,147

7.Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy.

Wennan ZHAO ; Yuling QIU ; Dexin KONG

Acta Pharmaceutica Sinica B 2017;7(1):27-37

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO